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Background
The double-blind placebo-controlled food challenge
(DBPCFC) is considered to be the gold standard for diag-
nosing food allergy in children. During the DBPCFC, both
objective and subjective symptoms are observed. Although
subjective symptoms are thought to be less specific than
objective symptoms, it is not known whether objective
symptoms have a stronger association with a true positive
result than subjective symptoms.
Aim
The aim of this study was to analyze whether subjective
symptoms are less specific than objective symptoms and
whether they lead to overdiagnosis compared to objective
symptoms, and also to rank symptoms according to
specificity.
Methods
Data were obtained from the food challenge unit database
of University Medical Center Groningen. We included
children that had a complete DBPCFC and a history of
suspected food allergy. We assessed the specificity of the
symptoms according to the relative risk (RR) and the
95% Confidence Interval (95%CI).
Results
Individual symptoms showed a wide range of RR (1.777 to
0.809). The symptom with the highest RR was utricaria
(RR= 1.977, 95% CI [1.857, 2.106]). However, the subjective
symptom “strange taste” (RR= 1.923, 95%CI [1.720, 2.151])
was the seventh most specific symptom on the list. Certain
symptoms, both subjective and objective, showed no signi-
ficant association with a positive DBPCFC and were thus
non-specific.
Conclusion
Symptoms differ in their specificity as indicated by a
broad range of RRs in relation to a positive test outcome.
Subjective symptoms are not less specific than the objec-
tive ones, and therefore do not lead to false positive
results and overdiagnosis. Protocols on interpretation of
DBPCFCs should probably be based on symptom speci-
ficity rather than whether symptoms are subjective or
objective.
Published: 28 February 2014
doi:10.1186/2045-7022-4-S1-P25
Cite this article as: Sideridou et al.: PD25 - Diagnostic specificity of
symptoms seen in Double Blind Placebo Control Food Challenges
(DBPCFCs). Do subjective symptoms lead to false positive test results
and overdiagnosis? Clinical and Translational Allergy 2014 4(Suppl 1):P25.
Department of Pediatric Pulmonology and Allergy, University Medical Centre
Groningen, University of Groningen, The Netherlands
Sideridou et al. Clinical and Translational Allergy 2014, 4(Suppl 1):P25
http://www.ctajournal.com/content/4/S1/P25
© 2014 Sideridou et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
